141 related articles for article (PubMed ID: 23194742)
21. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
22. CXCL1 Inhibition Regulates UVB-Induced Skin Inflammation and Tumorigenesis in Xpa-Deficient Mice.
Kunisada M; Hosaka C; Takemori C; Nakano E; Nishigori C
J Invest Dermatol; 2017 Sep; 137(9):1975-1983. PubMed ID: 28528167
[TBL] [Abstract][Full Text] [Related]
23. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
[TBL] [Abstract][Full Text] [Related]
24. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
25. Molecular studies of Japanese patients with group A xeroderma pigmentosum using polymerase chain reaction and restriction fragment length polymorphism and nonradioactive single strand conformation polymorphism analyses.
Sumitani S; Ishikawa Y; Ishikawa Y; Minami R
J Child Neurol; 1999 Mar; 14(3):168-72. PubMed ID: 10190268
[TBL] [Abstract][Full Text] [Related]
26. Xeroderma pigmentosum.
Kulkarni ML; Rani RS
Indian Pediatr; 1996 May; 33(5):394-8. PubMed ID: 8979588
[No Abstract] [Full Text] [Related]
27. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type.
Tanioka M; Masaki T; Ono R; Nagano T; Otoshi-Honda E; Matsumura Y; Takigawa M; Inui H; Miyachi Y; Moriwaki S; Nishigori C
J Invest Dermatol; 2007 Jul; 127(7):1745-51. PubMed ID: 17344931
[TBL] [Abstract][Full Text] [Related]
28. A novel 5 nucleotide deletion in XPA gene is associated with severe neurological abnormalities.
Ghafouri-Fard S; Fardaei M; Miryounesi M
Gene; 2016 Jan; 576(1 Pt 2):379-80. PubMed ID: 26302748
[No Abstract] [Full Text] [Related]
29. Case of xeroderma pigmentosum group A with West syndrome.
Nakao A; Tanizaki H; Yu A; Araki A; Moriwaki S
J Dermatol; 2018 Dec; 45(12):e334-e336. PubMed ID: 29797530
[No Abstract] [Full Text] [Related]
30. [Xeroderma pigmentosum (XP) : A genetic disease sheds light on UV-induced skin cancer].
Emmert B; Hallier E; Schön MP; Emmert S
Hautarzt; 2011 Feb; 62(2):91-7. PubMed ID: 21243329
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma pigmentosum in the United kingdom.
Lehmann AR
Photochem Photobiol; 2015; 91(2):484-5. PubMed ID: 24943090
[TBL] [Abstract][Full Text] [Related]
32. A genetic cluster of patients with variant xeroderma pigmentosum with two different founder mutations.
Munford V; Castro LP; Souto R; Lerner LK; Vilar JB; Quayle C; Asif H; Schuch AP; de Souza TA; Ienne S; Alves FIA; Moura LMS; Galante PAF; Camargo AA; Liboredo R; Pena SDJ; Sarasin A; Chaibub SC; Menck CFM
Br J Dermatol; 2017 May; 176(5):1270-1278. PubMed ID: 27664908
[TBL] [Abstract][Full Text] [Related]
33. Convulsive episodes in patients with group A xeroderma pigmentosum.
Kohyama J; Furushima W; Sugawara Y; Shimohira M; Hasegawa T; Hayashi M; Moriwaki S; Iwakawa Y
Acta Neurol Scand; 2005 Oct; 112(4):265-9. PubMed ID: 16146498
[TBL] [Abstract][Full Text] [Related]
34. Xeroderma pigmentosum. A clinical study of 24 Libyan cases.
Khatri ML; Shafi M; Mashina A
J Am Acad Dermatol; 1992 Jan; 26(1):75-8. PubMed ID: 1732340
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
36. Skin tumors of xeroderma pigmentosum (I).
Kobayashi M; Satoh Y; Irimajiri T; Mitoh Y; Kozuka T; Sato K; Ichihashi M; Nakanishi T
J Dermatol; 1982 Aug; 9(4):319-22. PubMed ID: 6759550
[No Abstract] [Full Text] [Related]
37. Early onset of skin and oral cavity neoplasms in xeroderma pigmentosum.
Kraemer KH; Lee MM; Scotto J
Lancet; 1982 Jan; 1(8262):56-7. PubMed ID: 6119457
[No Abstract] [Full Text] [Related]
38. The molecular basis of xeroderma pigmentosum.
Copeland NE; Hanke CW; Michalak JA
Dermatol Surg; 1997 Jun; 23(6):447-55. PubMed ID: 9217796
[TBL] [Abstract][Full Text] [Related]
39. Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.
Doubaj Y; Laarabi FZ; Elalaoui SC; Barkat A; Sefiani A
J Dermatol; 2012 Apr; 39(4):382-4. PubMed ID: 22211393
[TBL] [Abstract][Full Text] [Related]
40. Autophagy induction on impaired spermatogenesis of xeroderma pigmentosum group A gene-deficient mice.
Nakane H; Higaki K; Koyama Y; Nanba E; Kaidoh T
Biomed Res; 2020; 41(5):237-242. PubMed ID: 33071259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
